Lobbying

Marshfield Clinic Health System's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q4 2022; the issues it reports most are Agriculture and Health Issues.

Marshfield Clinic Health System

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$180K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Marshfield Clinic Health System lobbying by quarter
Marshfield Clinic Health System lobbying by quarter
QuarterAmountReports
Q4 2022$60K1
Q1 2023$70K1
Q2 2023$60K1
Q3 2023$50K1
Q4 2023$50K1
Q1 2024$50K1
Q2 2024$60K1
Q3 2024$60K1
Q4 2024$60K1
Q1 2025$60K1
Q2 2025$60K1
Q3 2025$60K1
Q4 2025$60K1
Q1 2026$60K1
Q2 2026$60K1
Q3 2026$00

By issue

  • Agriculture$125.7K · 15 reports
  • Health issues$125.7K · 15 reports
  • Insurance$125.7K · 15 reports
  • Medical research and clinical labs$125.7K · 15 reports
  • Medicare and Medicaid$125.7K · 15 reports
  • Telecommunications$125.7K · 15 reports
  • Tobacco$125.7K · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)15 reports
  • Health & Human Services, Dept of (HHS)15 reports
  • Health Resources & Services Administration (HRSA)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
In-houseMarshfield Clinic Health System$880K15 quarters

Former officials lobbying for it

Former position
BRADLEY E WOLTERSUS Department of Health and Human Services: White House Liaison (May 2013-January 2016) Chief of Staff, Assistant Secretary for Health (May 2010-May 2013) US Senate Office of Senator Barack ObamaQ2 2026

Lobbying reports

Filed by
07/23for Q2In-house$60K
04/17for Q1In-house$60K
01/22for Q4 2025In-house$60K
25/10/20for Q3 2025In-house$60K
25/07/22for Q2 2025In-house$60K
25/04/15for Q1 2025In-house$60K
25/01/21for Q4 2024In-house$60K
24/10/03for Q3 2024In-house$60K
24/07/18for Q2 2024In-house$60K
24/04/29for Q1 2024In-house$50K
24/01/09for Q4 2023In-house$50K
23/10/11for Q3 2023In-house$50K
23/07/18for Q2 2023In-house$60K
23/04/12for Q1 2023In-house$70K
23/01/11for Q4 2022In-house$60K